2017年的运动神经元病：运动神经元病治疗进展 - Suppr

Suppr

超能文献

Motor neuron disease in 2017: Progress towards therapy in motor neuron disease.

作者信息

Kiernan Matthew C

机构信息

Brain and Mind Centre, University of Sydney, New South Wales 2040, Australia.

出版信息

Nat Rev Neurol. 2018 Feb;14(2):65-66. doi: 10.1038/nrneurol.2017.186. Epub 2018 Jan 19.

DOI:10.1038/nrneurol.2017.186

PMID:29348545

Abstract

摘要

相似文献

Motor neuron disease in 2017: Progress towards therapy in motor neuron disease.

Nat Rev Neurol. 2018 Feb;14(2):65-66. doi: 10.1038/nrneurol.2017.186. Epub 2018 Jan 19.

Advances in therapy for spinal muscular atrophy: promises and challenges.

Nat Rev Neurol. 2018 Apr;14(4):214-224. doi: 10.1038/nrneurol.2018.4. Epub 2018 Feb 9.

Motor neuron disease: systematic reviews of treatment for ALS and SMA.

Br Med Bull. 2010;93:145-59. doi: 10.1093/bmb/ldp049. Epub 2009 Dec 15.

Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.

Neurosci Lett. 2012 Oct 11;527(2):78-84. doi: 10.1016/j.neulet.2012.04.079. Epub 2012 May 8.

Edaravone for the treatment of amyotrophic lateral sclerosis.

Expert Rev Neurother. 2019 Mar;19(3):185-193. doi: 10.1080/14737175.2019.1581610. Epub 2019 Feb 27.

Edaravone May Prevent Ferroptosis in ALS.

Curr Drug Targets. 2020;21(8):776-780. doi: 10.2174/1389450121666200220123305.

[Trypan red in therapy of amyotrophic lateral sclerosis and of myelopathic muscular atrophy].

Rass Int Clin Ter. 1955 Mar 31;35(6):197-206.

Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethics.

CMAJ. 2020 Mar 23;192(12):E319-E320. doi: 10.1503/cmaj.191236.

Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosis-a systematic review and meta-analysis.

Neurol Sci. 2019 Feb;40(2):235-241. doi: 10.1007/s10072-018-3653-2. Epub 2018 Nov 27.

Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.

Hum Mol Genet. 2014 Sep 15;23(R1):R27-34. doi: 10.1093/hmg/ddu205. Epub 2014 May 12.

引用本文的文献

: A HERV Turn-On for Autoimmunity, Neurodegeneration, and Cancer?

Microorganisms. 2024 Sep 13;12(9):1890. doi: 10.3390/microorganisms12091890.

Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy.

Behav Neurol. 2024 Mar 16;2024:1228194. doi: 10.1155/2024/1228194. eCollection 2024.

The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy.

Mol Neurobiol. 2023 Nov;60(11):6330-6345. doi: 10.1007/s12035-023-03472-y. Epub 2023 Jul 14.

A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?

Transl Neurodegener. 2021 Aug 10;10(1):29. doi: 10.1186/s40035-021-00250-5.

Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis.

Int J Mol Sci. 2019 May 28;20(11):2616. doi: 10.3390/ijms20112616.

Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions.

Front Neurosci. 2019 Feb 28;13:135. doi: 10.3389/fnins.2019.00135. eCollection 2019.

Microhexagon gradient array directs spatial diversification of spinal motor neurons.

Theranostics. 2019 Jan 1;9(2):311-323. doi: 10.7150/thno.29755. eCollection 2019.

Interaction of Half Oxa-/Half -Platin Complex with Human Superoxide Dismutase and Induced Reduction of Neurotoxicity.

ACS Med Chem Lett. 2018 Oct 1;9(11):1094-1098. doi: 10.1021/acsmedchemlett.8b00199. eCollection 2018 Nov 8.

Geographic Analysis of Motor Neuron Disease Mortality and Heavy Metals Released to Rivers in Spain.

Int J Environ Res Public Health. 2018 Nov 11;15(11):2522. doi: 10.3390/ijerph15112522.

Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

JCI Insight. 2018 Oct 4;3(19):123249. doi: 10.1172/jci.insight.123249.

本文引用的文献

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.

N Engl J Med. 2017 Nov 2;377(18):1723-1732. doi: 10.1056/NEJMoa1702752.

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):156-161. doi: 10.1136/jnnp-2017-317077. Epub 2017 Oct 30.

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.

Neurology. 2017 Oct 31;89(18):1915-1922. doi: 10.1212/WNL.0000000000004606. Epub 2017 Oct 4.

Cortical influences drive amyotrophic lateral sclerosis.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):917-924. doi: 10.1136/jnnp-2017-315573. Epub 2017 Jul 14.

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Lancet Neurol. 2017 Jul;16(7):505-512. doi: 10.1016/S1474-4422(17)30115-1. Epub 2017 May 15.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet Neurol. 2017 Mar;16(3):208-216. doi: 10.1016/S1474-4422(16)30399-4. Epub 2017 Jan 28.

The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder.

J Neurol Neurosurg Psychiatry. 2015 May;86(5):481-2. doi: 10.1136/jnnp-2014-309829. Epub 2014 Dec 30.

Amyotrophic lateral sclerosis.

Lancet. 2011 Mar 12;377(9769):942-55. doi: 10.1016/S0140-6736(10)61156-7. Epub 2011 Feb 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验